| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| VIB-9600 | VIB-9600; MEDI-9600 | Phase 1 Clinical | Medimmune Llc, Viela Bio Inc, Horizon Therapeutics PLC | Autoimmune Diseases | Details |
| QLS-21908 | QLS-21908 | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | Autoimmune Diseases | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



